Childrens Health Defense – Pfizer Asks FDA to Authorize Booster Shots for All Adults, as Vaccine Maker Puts ‘Profits’ Over ‘Public Health’

Pfizer and BioNTech said their FDA request is based on results of a study, conducted by the two companies, which has not been published or peer-reviewed.By Megan Redshaw


Pfizer and BioNTech on Tuesday asked the U.S. Food and Drug Administration (FDA) to authorize a third dose of their COVID vaccine for all people 18 and older, even though advisory panels to the FDA and Centers for Disease Control and Prevention (CDC) in September overwhelmingly rejected a similar request.

The companies said their new request is based on the results of a study, conducted by Pfizer and BioNTech, which has not been published or peer-reviewed.

The companies said the study of more than 10,000 volunteers showed vaccine efficacy against symptomatic infection of 95% or greater for people receiving the booster.

According to the Associated Press, a median of 11 months after receiving their last Pfizer vaccine dose, trial participants were given either a third booster dose or a placebo shot. Researchers tracked any infections that occurred at least a week later.

So far, five cases of symptomatic COVID occurred among booster recipients compared to 109 cases in the placebo group.

Pfizer did not disclose how many participants experienced asymptomatic infection, or whether the clinical trial included individuals with natural immunity acquired from previous SARS-CoV-2 infection — as did Pfizer’s clinical trial for 5 to 11 years olds.

According to CDC data, about 25 million people in the U.S. have received a COVID booster. It’s not clear how many would qualify for a booster if the FDA signs off on Pfizer-BioNTech’s request.

Air Force Research Lab puts money up for tools to stop future Snowdens

Air Force Research Lab puts money up for tools to stop future Snowdens

Whistleblowers have demonstrated how vulnerable military and intelligence networks are to trusted insiders over the past few years, much to the embarrassment of the organizations charged with defending those networks. To prevent future Edward Snowdens and Chelsea (formerly Bradley) Mannings from adding insult to injury, the Air Force Research Lab (AFRL) recently added a new request to its ongoing cybersecurity research program that seeks technology to shut down the insider threat.

The Cyber Awareness and Resilience Research program, a broad effort to develop new information security technologies, has modified a number of its new research priorities, including “Counter-Insider Modeling.” The goal of the newly budgeted research: to “research, design, and develop techniques to identify, characterize, categorize, and manage insider threats at the tactical and strategic levels (and to) assess and determine tools to conduct fingerprinting of data and the management of such data across a diverse network.”

The anti-insider threat research is one of five new areas for which the AFRL has budgeted a total of $24.4 million in order to develop systems that the military can implement to better secure its networks. Other focus areas for the research include developing better authentication technology “to provide secure end-to-end identity attributable device authentication across security and administrative domains”—technology that might prevent the sort of credential escalation that Snowden allegedly used to gain access to National Security Agency intranet resources.